KR0137786B1
(ko)
*
|
1988-11-15 |
1998-05-15 |
하마구찌 미찌오 |
심장 또는 뇌의 허혈성 질환의 치료, 예방제
|
ATE127472T1
(de)
*
|
1989-06-20 |
1995-09-15 |
Yamasa Shoyu Kk |
Zwischenverbindung für 2- alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2- alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat.
|
WO1991009864A1
(en)
*
|
1990-01-04 |
1991-07-11 |
Yamasa Shoyu Kabushiki Kaisha |
Drug for treating or preventing ischemic diseases of heart or brain
|
GB9014618D0
(en)
*
|
1990-06-30 |
1990-08-22 |
Wellcome Found |
Process for the preparation of pyrimidine nucleosides
|
US5189027A
(en)
*
|
1990-11-30 |
1993-02-23 |
Yamasa Shoyu Kabushiki Kaisha |
2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
|
JP2740362B2
(ja)
*
|
1991-02-12 |
1998-04-15 |
ヤマサ醤油株式会社 |
安定な固体状2‐オクチニルアデノシンおよびその製造法
|
IT1254915B
(it)
*
|
1992-04-24 |
1995-10-11 |
Gloria Cristalli |
Derivati di adenosina ad attivita' a2 agonista
|
US5705491A
(en)
*
|
1992-10-27 |
1998-01-06 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Adenosine deaminase inhibitor
|
US6514949B1
(en)
|
1994-07-11 |
2003-02-04 |
University Of Virginia Patent Foundation |
Method compositions for treating the inflammatory response
|
US6448235B1
(en)
|
1994-07-11 |
2002-09-10 |
University Of Virginia Patent Foundation |
Method for treating restenosis with A2A adenosine receptor agonists
|
WO1996003134A1
(en)
*
|
1994-07-21 |
1996-02-08 |
Thomas Jefferson University |
Treatment of diarrhea with 2-substituted adenosine derivatives
|
US6117878A
(en)
*
|
1998-02-24 |
2000-09-12 |
University Of Virginia |
8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
|
JP3619017B2
(ja)
|
1998-06-24 |
2005-02-09 |
日本臓器製薬株式会社 |
新規アラビノシルアデニン誘導体
|
US7378400B2
(en)
*
|
1999-02-01 |
2008-05-27 |
University Of Virginia Patent Foundation |
Method to reduce an inflammatory response from arthritis
|
US7427606B2
(en)
*
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
US6232297B1
(en)
*
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
AU4343500A
(en)
|
1999-04-16 |
2000-11-02 |
Schering Corporation |
Use of azetidinone compounds
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
USRE47351E1
(en)
|
1999-06-22 |
2019-04-16 |
Gilead Sciences, Inc. |
2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
|
US6214807B1
(en)
*
|
1999-06-22 |
2001-04-10 |
Cv Therapeutics, Inc. |
C-pyrazole 2A A receptor agonists
|
US6403567B1
(en)
|
1999-06-22 |
2002-06-11 |
Cv Therapeutics, Inc. |
N-pyrazole A2A adenosine receptor agonists
|
US6180615B1
(en)
*
|
1999-06-22 |
2001-01-30 |
Cv Therapeutics, Inc. |
Propargyl phenyl ether A2A receptor agonists
|
CA2671940A1
(en)
|
2000-02-23 |
2001-08-30 |
Cv Therapeutics, Inc. |
Identification of partial agonists of the a2a adenosine receptor
|
US6670334B2
(en)
|
2001-01-05 |
2003-12-30 |
University Of Virginia Patent Foundation |
Method and compositions for treating the inflammatory response
|
SG176313A1
(en)
*
|
2001-10-01 |
2011-12-29 |
Univ Virginia Patent Found |
2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
|
AU2002359732A1
(en)
*
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies
|
US8470801B2
(en)
|
2002-07-29 |
2013-06-25 |
Gilead Sciences, Inc. |
Myocardial perfusion imaging methods and compositions
|
CA2492855C
(en)
*
|
2002-07-29 |
2012-09-18 |
Cv Therapeutics, Inc. |
Myocardial perfusion imaging using a2a receptor agonists
|
US20050020915A1
(en)
*
|
2002-07-29 |
2005-01-27 |
Cv Therapeutics, Inc. |
Myocardial perfusion imaging methods and compositions
|
US20050033044A1
(en)
*
|
2003-05-19 |
2005-02-10 |
Bristol-Myers Squibb Pharma Company |
Methods for preparing 2-alkynyladenosine derivatives
|
TWI346109B
(en)
|
2004-04-30 |
2011-08-01 |
Otsuka Pharma Co Ltd |
4-amino-5-cyanopyrimidine derivatives
|
WO2006028618A1
(en)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
US7605143B2
(en)
*
|
2004-08-02 |
2009-10-20 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity
|
WO2006023272A1
(en)
*
|
2004-08-02 |
2006-03-02 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having a2a agonist activity
|
KR20070083714A
(ko)
*
|
2004-10-20 |
2007-08-24 |
씨브이 쎄러퓨틱스, 인코포레이티드 |
A2a 아데노신 수용체 작용제의 용도
|
SI1989214T1
(sl)
|
2006-02-03 |
2016-10-28 |
Gilead Sciences, Inc. |
Postopek za pripravo A2A-adenozin receptor agonista in njegovih polimorfov
|
US20080027022A1
(en)
*
|
2006-02-08 |
2008-01-31 |
Linden Joel M |
Method to treat gastric lesions
|
WO2007120972A2
(en)
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
JP2009541354A
(ja)
*
|
2006-06-22 |
2009-11-26 |
シーブイ・セラピューティクス・インコーポレイテッド |
虚血の治療におけるa2aアデノシン受容体アゴニストの使用
|
WO2008028140A1
(en)
*
|
2006-09-01 |
2008-03-06 |
Cv Therapeutics, Inc. |
Methods and compositions for increasing patient tolerability during myocardial imaging methods
|
US20090081120A1
(en)
*
|
2006-09-01 |
2009-03-26 |
Cv Therapeutics, Inc. |
Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
|
JP2011502101A
(ja)
*
|
2006-09-29 |
2011-01-20 |
ギリアード・パロ・アルト・インコーポレイテッド |
肺疾患の病歴を有する患者における心筋画像化法
|
WO2008086096A2
(en)
*
|
2007-01-03 |
2008-07-17 |
Cv Therapeutics, Inc. |
Myocardial perfusion imaging
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
US20110064671A1
(en)
|
2008-03-10 |
2011-03-17 |
Cornell University |
Modulation of blood brain barrier permeability
|
KR20110063556A
(ko)
*
|
2008-09-29 |
2011-06-10 |
길리애드 사이언시즈, 인코포레이티드 |
다검출 전산화 단층 촬영법에 사용하기 위한 a-2-알파 수용체 길항제와 속도 조절제의 조합물
|
US9822141B2
(en)
|
2012-08-01 |
2017-11-21 |
Lewis And Clark Pharmaceuticals, Inc. |
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists
|
CN104582709A
(zh)
|
2012-08-01 |
2015-04-29 |
路易斯与克拉克药品公司 |
作为a2a激动剂的n-烷基2-(双取代的)炔基腺苷-5’-糖醛酰胺
|